Different doses of consensus interferon plus ribavirin in patients with hepatitis C virus genotype 1 relapsed after interferon monotherapy: A randomized controlled trial

Table 1 HCV-RNA clearance at different time points in 2 groups after treatment n (%)

	Group A	Group B	P
	(n = 22)	(n = 23)
At 26 wk (EVR)	7 (31.8)	8 (34.8)	NS
At 52 wk (ETR)	7 (31.8)	8 (34.8)	NS
At 76 wk (SVR)	6 (27.3)	6 (26.1)	NS

EVR: Early virological response; ETR: End-of-treatment response; SVR: Sustained virological response; NS: Not significant.

Table 2 ALT normalization at different time points in 2 groups after treatment n (%)

	Group A	Group B	P
	(n = 22)	(n = 23)
At 4 wk	12 (54.5)	10 (43.5)	NS
At 12 wk	13 (59.1)	13 (56.5)	NS
At 26 wk (EVR)	13 (59.1)	13 (56.5)	NS
At 52 wk (ETR)	12 (54.5)	10 (43.5)	NS
At 76 wk (SVR)	6 (27.3)	6 (26.2)	NS

EVR: Early virological response; ETR: End-of-treatment response; SVR: Sustained virological response; NS: Not significant.